Biotech · Private company
Rion Inc.
Track this companyFree. Adds Rion Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- PEP (Purified Exosome Product) / TISSEELPhase 2 · Diabetic Foot UlcerClinicalTrials.gov · fetched Nov 12, 2026
- PEP-TISSEELPhase 2 · Chronic Radiation UlcerClinicalTrials.gov · fetched Nov 12, 2026
- TISSEEL Fibrin Sealant KITPhase 2 · Chronic Radiation UlcerClinicalTrials.gov · fetched Nov 12, 2026
- 10% PEPPhase 1 · Skin GraftClinicalTrials.gov · fetched Nov 12, 2026
- 20% PEPPhase 1 · Skin GraftClinicalTrials.gov · fetched Nov 12, 2026
- PEPPhase 1 · Knee OsteoarthritisClinicalTrials.gov · fetched Nov 12, 2026
- PEP/EuflexxaPhase 1 · Knee OsteoarthritisClinicalTrials.gov · fetched Nov 12, 2026
- TISSEELPhase 1 · Skin GraftClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation UlcerPHASE1_PHASE2 · NOT_YET_RECRUITING · started Jun 1, 2025ClinicalTrials.gov NCT06793748 · fetched Nov 12, 2026
- Phase 1b Clinical Trial to Evaluate PEP and EUFLEXXA for Knee Osteoarthritis (KOA)PHASE1 · UNKNOWN · started Nov 1, 2024ClinicalTrials.gov NCT06463132 · fetched Nov 12, 2026
- Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU)PHASE2 · COMPLETED · started Feb 27, 2024ClinicalTrials.gov NCT06319287 · fetched Nov 12, 2026
- PEP on a Skin Graft Donor Site WoundPHASE1 · UNKNOWN · started Mar 16, 2021ClinicalTrials.gov NCT04664738 · fetched Nov 12, 2026